NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-26-003 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-26-002 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities
Notice NOT-NS-24-079 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-25-004 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

NIDCD Individual Fellowship Pre-Application Information Session
Notice NOT-DC-24-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research
Notice NOT-CA-24-047 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
Funding Opportunity PAR-24-132 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction. This NOFO supports small business concerns (SBCs) in employing and developing researchers as entrepreneurial Program Directors/Principal Investigators (PDs/PIs). In addition to augmenting scientifi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
Funding Opportunity PA-24-180 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the ca...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Funding Opportunity PA-24-178 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the ca...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding

Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)
Notice NOT-AI-24-046 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding

Notice of Change to Key Date Section in PAR-24-080, Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
Notice NOT-AI-24-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding

Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-24-025 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support basic and applied research to understand and improve durable immune responses to candidate HIV vaccines. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding

Notice to Update PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
Notice NOT-DA-24-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding

Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
Notice NOT-DA-24-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding

Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
Funding Opportunity RFA-NR-24-006 from the NIH Guide for Grants and Contracts. Research shows that intersecting systems of privilege and oppression produce and sustain wide and unjust variations in health. The Axes Initiative will support research to understand health at the intersections of social statuses such as race, ethnicity, socioeconomic status, sexual orientation, and ability, by examining contributions of social and other determinants of health. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2024 Category: Research Source Type: funding